For the quarter ending 2026-03-31, CNO had $170,800K increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Insurance policy income | 613,300 | 621,500 | 598,600 | 1,182,400 |
| Net investment income | 387,800 | 382,500 | 372,200 | 748,200 |
| Fee revenue and other income | 60,900 | 45,000 | 36,100 | 98,500 |
| Insurance policy benefits | 414,400 | 399,700 | 405,900 | 822,900 |
| Interest expense | 32,400 | 71,000 | 44,900 | 114,400 |
| Deferrable policy acquisition costs and sales inducements | 114,100 | 121,500 | 133,000 | 244,800 |
| Other operating costs | 336,400 | 232,900 | 216,100 | 564,500 |
| Income taxes | 15,900 | 28,200 | 9,200 | 300 |
| Net cash provided by operating activities | 148,800 | 195,700 | 197,800 | 282,200 |
| Sales of investments | 3,896,000 | 959,100 | 598,500 | 1,716,900 |
| Maturities and redemptions of investments | 758,700 | 1,311,400 | 946,400 | 1,263,100 |
| Purchases of investments | 4,834,200 | 3,167,200 | 1,661,100 | 3,631,200 |
| Net purchases of trading securities | - | 0 | 0 | 0 |
| Other, net | 4,600 | 4,100 | -10,100 | 9,200 |
| Net cash used by investing activities | -184,100 | -900,800 | -106,100 | -660,400 |
| Issuance of notes payable, net | - | 0 | 0 | 0 |
| Payments on notes payable | - | 0 | 0 | 500,000 |
| Issuance of common stock | 5,600 | 2,000 | 2,500 | 7,100 |
| Payments to repurchase common stock | 73,300 | 60,200 | 60,600 | 210,600 |
| Proceeds from financing arrangements | - | 0 | - | - |
| Common stock dividends paid | 17,100 | 16,200 | 16,400 | 33,600 |
| Payments on financing arrangements | 4,000 | 4,000 | 3,800 | 7,600 |
| Amounts received for deposit products | 560,700 | 1,044,600 | 955,400 | 1,234,100 |
| Withdrawals from deposit products | 515,800 | 519,100 | 464,500 | 1,402,100 |
| Proceeds From | 450,000 | 0 | 250,000 | 526,800 |
| Related to variable interest entities | - | 0 | - | - |
| Repayments Of | 200,000 | 100 | 249,900 | 273,800 |
| Related to variable interest entities | 0 | 0 | 78,800 | 143,800 |
| Net cash provided (used) by financing activities | 206,100 | 447,000 | 333,900 | -803,500 |
| Net increase (decrease) in cash and cash equivalents | 170,800 | -258,100 | 425,600 | -1,181,700 |
| Cash and cash equivalents - unrestricted and including held by variable interest entities, beginning of period | 983,500 | 1,241,600 | 1,997,700 | - |
| Cash and cash equivalents - unrestricted and including held by variable interest entities, end of period | 1,154,300 | 983,500 | 1,241,600 | - |
CNO Financial Group, Inc. (CNO)
CNO Financial Group, Inc. (CNO)